• Revelation Biosciences will implement a 1-for-7 reverse stock split effective October 20, 2026.
• Shares will begin trading on a split-adjusted basis that day under the existing symbol REVB.
• The split aims to raise the share price to regain compliance with Nasdaq Capital Market's minimum bid requirement.
• Fractional shares resulting from the split will be rounded up to the nearest whole share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revelation Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261016185360) on October 16, 2026, and is solely responsible for the information contained therein.